Celularity Inc. (CELU)
NASDAQ·Healthcare·Biotechnology
$1.43
-0.35%
Mkt Cap $44.58M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+109.8%
Consensus $3.00 vs current $1.43
NASDAQ·Healthcare·Biotechnology
$1.43
-0.35%
Mkt Cap $44.58M
No recent rating data.
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
+109.8%
Consensus $3.00 vs current $1.43